Grocers Reshape Stores as GLP-1 Use Grows
Giant Food and Ahold Delhaize USA are changing layouts and merchandising, while Carrefour applies lessons from Brazil to Europe.
Updated on Nov. 17, 2026 in Diabetes

Live Poll
Do you trust grocery stores to make healthy food easier to find and afford?
Executives from Giant Food, Ahold Delhaize USA and Carrefour discussed store changes at EnsembleIQ's inaugural GLP-1 Summit on November 12, 2026. Retailers say shoppers taking GLP-1 drugs are shifting purchases away from large sweets, salty chips and sugary sodas.
Why it matters
Grocers are adjusting shelf space and product placement as GLP-1 medications change what consumers buy. Ahold Delhaize positions its stores as health destinations that connect with the broader health care ecosystem, a shift that could affect how Americans shop for food.
Adult GLP-1 penetration in Brazil stands at 6%, a figure retailers expect to climb once generic semaglutides reach the market and lower prices. Reported figures for U.S. penetration and measured sales changes at these grocers were not disclosed.
The players
Giant Food
Giant Food is a supermarket chain operating in the Mid-Atlantic region of the United States, known for its regional grocery presence.
Ahold Delhaize USA
Ahold Delhaize USA is the American arm of the Dutch-Belgian grocery conglomerate Ahold Delhaize, which operates several large U.S. supermarket banners.
Carrefour
Carrefour is a French multinational retailer and one of the largest grocery chains in Europe, with significant operations in Brazil.
The details
Giant Food is editing its baskets rather than shrinking them, stocking traditional, organic, gluten-free and protein-enhanced pastas in the same section to aid comparison. Carrefour is downsizing shelf space for sweets and alcohol, using 'better eating' tags to highlight protein and fiber, and uses Hopla, a generative AI assistant, to suggest automated swaps. Giant Food also offers digital and in-store shop-alongs to educate shoppers.
Timeline
November 12, 2026: EnsembleIQ holds its inaugural GLP-1 Summit, where the retail executives spoke.
2030: Industry leaders anticipate that market winners will merge food, healthcare, drugstore, beauty and AI into one wellness experience.
Health Landscape
The retail response follows the rapid uptake of GLP-1 medications such as semaglutide, which are changing eating habits across populations. Grocers are now treating these drugs as a structural shift in demand rather than a passing diet trend.
Shoppers taking GLP-1 medications may find fewer large sweets, salty chips and sugary sodas on shelves, with more protein- and fiber-labeled options. Grocers are also adding shop-alongs and AI-driven swap suggestions that can help households adjust their buying habits.
The takeaway
Grocery shelves are beginning to reflect how GLP-1 medications change appetite and purchasing, so shoppers can expect more protein- and fiber-focused choices. Comparing labels and trying guided swaps may help households adapt their buying habits.
Further reading
For more on how these medications are changing eating patterns, see our Diabetes coverage.
Source note: This article includes information reported by Progressive Grocer.
Live Poll
Do you trust grocery stores to make healthy food easier to find and afford?






